Published date: 2 February 2021
This notice was replaced on 2 July 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 2 July 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Medical equipments, pharmaceuticals and personal care products - 33000000
Location of contract
North West
Value of contract
£1,900,000
Procurement reference
AHCNHS001-DN505223-92892580
Published date
2 February 2021
Closing date
5 March 2021
Closing time
12pm
Contract start date
1 May 2021
Contract end date
30 April 2024
Contract type
Supply contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Clatterbridge Cancer Centre is looking to procure an upgrade to its current low-energy proton facility on the Wirral site.
The National Eye Proton Therapy Centre at Clatterbridge Cancer Centre is the only provider of proton beam therapy for ocular tumours in the NHS. It has been operational for over 30 years and has treated more than 3,000 patients with proton beam therapy. The current service treats on average more than 250 patients annually (300 patients were treated in 2019/20) and is a world leader in the field.
The cyclotron, manufactured by Scanditronix (Model: MC-62 PF isochronous cyclotron), was installed at Clatterbridge Cancer Centre's Wirral site in 1984 and remains reliable. Many of the major equipment components remain from the late 1980s and are therefore more than 30 years old. The hardware and associated software used in the low energy eye proton service are mostly bespoke, non CE-marked, and developed by the in-house engineering and physics team during the late 1980s and early 1990s. Service support from the original manufacturer ceased in 2009, and sales of spares, on a 'best endeavours' basis, ended in August 2017.
Whilst the main accelerating structures are of a robust and reliable design, a number of system, sub-system and component choices in the current technology that would not be favoured if the machine was specified and built in 2021. More advanced technologies, improved manufacturing processes, enhanced monitoring diagnostics and instrumentation are now commercially available. The main areas for upgrade relate to the control system and include the cyclotron control system, dosimetry monitoring and control system, programmable logic controller and human machine interface.
More information
Additional text
-
All documents relating to this opportunity can be accessed free of charge via the Trusts Procontract e-Tendering system.
Suppliers can register at the following URL - www.supplying2nhs.org
All communication including clarification questions must be made via the messaging portal within Procontract.
PLEASE NOTE: ALDER HEY CHILDREN'S HOSPITAL NHS FOUNDATION TRUST IS ACTING AS AN AGENT ON BEHALF OF THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST FOR THIS PROCUREMENT EXERCISE. THE FINAL CONTRACT WILL BE BETWEEN THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST AND THE AWARDED SUPPLIER
About the buyer
Contact name
Richard Jolley
Address
Eaton Road
West Derby
Liverpool
L12 2AP
United Kingdom
Share this notice
All content is available under the
